A citation-based method for searching scientific literature

Martin Köbel, Anna M Piskorz, Sandra Lee, Shuhong Lui, Cecile LePage, Francesco Marass, Nitzan Rosenfeld, Anne-Marie Mes Masson, James D Brenton. J Pathol Clin Res 2016
Times Cited: 184







List of co-cited articles
528 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.
Martin Köbel, Brigitte M Ronnett, Naveena Singh, Robert A Soslow, C Blake Gilks, W Glenn McCluggage. Int J Gynecol Pathol 2019
123
29

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.
Naveena Singh, Anna M Piskorz, Tjalling Bosse, Mercedes Jimenez-Linan, Brian Rous, James D Brenton, C Blake Gilks, Martin Köbel. J Pathol 2020
63
34

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
20


An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.
Martin Köbel, Kurosh Rahimi, Peter F Rambau, Christopher Naugler, Cécile Le Page, Liliane Meunier, Manon de Ladurantaye, Sandra Lee, Samuel Leung, Ellen L Goode,[...]. Int J Gynecol Pathol 2016
113
14

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.
Anna Yemelyanova, Russell Vang, Malti Kshirsagar, Dan Lu, Morgan A Marks, Ie Ming Shih, Robert J Kurman. Mod Pathol 2011
303
12

Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.
Martin Köbel, Li Luo, Xin Grevers, Sandra Lee, Angela Brooks-Wilson, C Blake Gilks, Nhu D Le, Linda S Cook. Int J Gynecol Pathol 2019
25
40

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
460
10

Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
Basile Tessier-Cloutier, Kim E Kortekaas, Emily Thompson, Jennifer Pors, Julia Chen, Julie Ho, Leah M Prentice, Melissa K McConechy, Christine Chow, Lily Proctor,[...]. Mod Pathol 2020
39
25

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
201
9

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
304
9

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
87
10

A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
336
8

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Tjalling Bosse, Remi A Nout, Jessica N McAlpine, Melissa K McConechy, Heidi Britton, Yaser R Hussein, Carlene Gonzalez, Raji Ganesan, Jane C Steele, Beth T Harrison,[...]. Am J Surg Pathol 2018
112
8

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.
Martin Köbel, Alexander Reuss, Andreas du Bois, Stefan Kommoss, Friedrich Kommoss, Dongxia Gao, Steve E Kalloger, David G Huntsman, C Blake Gilks. J Pathol 2010
115
8

The molecular origin and taxonomy of mucinous ovarian carcinoma.
Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, Michael S Anglesio, George Au-Yeung, Maret Böhm,[...]. Nat Commun 2019
51
15

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Robert A Soslow, Guangming Han, Kay J Park, Karuna Garg, Narciso Olvera, David R Spriggs, Noah D Kauff, Douglas A Levine. Mod Pathol 2012
132
8


Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Carlos Parra-Herran, Jordan Lerner-Ellis, Bin Xu, Sam Khalouei, Dina Bassiouny, Matthew Cesari, Nadia Ismiil, Sharon Nofech-Mozes. Mod Pathol 2017
42
16

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
C Blake Gilks, Esther Oliva, Robert A Soslow. Am J Surg Pathol 2013
199
7

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Aline Talhouk, Melissa K McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, Judith Pike, Michael Anglesio, Janice S Kwon,[...]. Cancer 2017
291
7

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
Peter F Rambau, Robert A Vierkant, Maria P Intermaggio, Linda E Kelemen, Marc T Goodman, Esther Herpel, Paul D Pharoah, Stefan Kommoss, Mercedes Jimenez-Linan, Beth Y Karlan,[...]. J Pathol Clin Res 2018
36
19



Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Audrey Petitjean, Ewy Mathe, Shunsuke Kato, Chikashi Ishioka, Sean V Tavtigian, Pierre Hainaut, Magali Olivier. Hum Mutat 2007
7

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Pauline Krämer, Aline Talhouk, Mary Anne Brett, Derek S Chiu, Evan S Cairns, Daniëlla A Scheunhage, Rory F L Hammond, David Farnell, Tayyebeh M Nazeran, Marcel Grube,[...]. Clin Cancer Res 2020
21
33

Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.
Sandra Lee, Anna M Piskorz, Cécile Le Page, Anne-Marie Mes Masson, Diane Provencher, David Huntsman, Wenqian Chen, Paul E Swanson, C Blake Gilks, Martin Köbel. Int J Gynecol Pathol 2016
24
25

Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.
Aline Talhouk, Lien N Hoang, Melissa K McConechy, Quentin Nakonechny, Joyce Leo, Angela Cheng, Samuel Leung, Winnie Yang, Amy Lum, Martin Köbel,[...]. Gynecol Oncol 2016
97
6

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
6

Interpretation of somatic POLE mutations in endometrial carcinoma.
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, Jessica N McAlpine, Remi Nout, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein, Tilman T Rau,[...]. J Pathol 2020
81
7

Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance.
Linda S Nooij, Natalja T Ter Haar, Dina Ruano, Natalia Rakislova, Tom van Wezel, Vincent T H B M Smit, Baptist J B M Z Trimbos, Jaume Ordi, Mariette I E van Poelgeest, Tjalling Bosse. Clin Cancer Res 2017
70
8

Immunohistochemical correlates of TP53 somatic mutations in cancer.
Balázs Murnyák, Tibor Hortobágyi. Oncotarget 2016
63
9

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
6

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Lauren C Peres, Kara L Cushing-Haugen, Martin Köbel, Holly R Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M Schildkraut, Jennifer A Doherty. J Natl Cancer Inst 2019
158
6

Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma.
M Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, Marc Ladanyi, Robert A Soslow. Mod Pathol 2021
12
50


Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Martin Köbel, Steve E Kalloger, David G Huntsman, Jennifer L Santos, Kenneth D Swenerton, Jeffrey D Seidman, C Blake Gilks. Int J Gynecol Pathol 2010
240
5

ARID1A mutations in endometriosis-associated ovarian carcinomas.
Kimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, Yongjun Zhao, Kane Tse, Thomas Zeng, Janine Senz, Melissa K McConechy, Michael S Anglesio, Steve E Kalloger,[...]. N Engl J Med 2010
5

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Ellen Stelloo, Tjalling Bosse, Remi A Nout, Helen J MacKay, David N Church, Hans W Nijman, Alexandra Leary, Richard J Edmondson, Melanie E Powell, Emma J Crosbie,[...]. Mod Pathol 2015
229
5

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Lien N Hoang, Melissa K McConechy, Martin Köbel, Guangming Han, Marjan Rouzbahman, Ben Davidson, Julie Irving, Rola H Ali, Sam Leung, Jessica N McAlpine,[...]. Am J Surg Pathol 2013
82
6

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
574
5

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
5

Whole-genome characterization of chemoresistant ovarian cancer.
Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, Dale W Garsed, Joshy George, Sian Fereday, Katia Nones, Prue Cowin, Kathryn Alsop, Peter J Bailey,[...]. Nature 2015
830
5

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Martin Köbel, Steve E Kalloger, Jon Carrick, David Huntsman, Haider Asad, Esther Oliva, Carol A Ewanowich, Robert A Soslow, C Blake Gilks. Am J Surg Pathol 2009
149
5


Prognostic significance of POLE proofreading mutations in endometrial cancer.
David N Church, Ellen Stelloo, Remi A Nout, Nadejda Valtcheva, Jeroen Depreeuw, Natalja ter Haar, Aurelia Noske, Frederic Amant, Ian P M Tomlinson, Peter J Wild,[...]. J Natl Cancer Inst 2014
176
5

Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
E Stelloo, A M L Jansen, E M Osse, R A Nout, C L Creutzberg, D Ruano, D N Church, H Morreau, V T H B M Smit, T van Wezel,[...]. Ann Oncol 2017
101
5

Immunohistochemical Profiling of Endometrial Serous Carcinoma.
Wenqian Chen, Arjumand Husain, Gregg S Nelson, Peter F Rambau, Shuhong Liu, Cheng-Han Lee, Sandra Lee, Máire A Duggan, Martin Köbel. Int J Gynecol Pathol 2017
35
14

The genetic landscape of endometrial clear cell carcinomas.
Deborah F DeLair, Kathleen A Burke, Pier Selenica, Raymond S Lim, Sasinya N Scott, Sumit Middha, Abhinita S Mohanty, Donavan T Cheng, Michael F Berger, Robert A Soslow,[...]. J Pathol 2017
104
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.